Can Hyperoxia be Prevented With Noninvasive Monitoring in On-pump Cardiac Surgery?
NCT ID: NCT04753554
Last Updated: 2021-02-15
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
30 participants
INTERVENTIONAL
2020-07-01
2020-10-15
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effects of Hyperoxia on Open Heart Surgery
NCT03012997
Oxygen Reserve Index Predicting Hypoxemia
NCT05480748
Can Atelectasis Be Prevented With Oxygen Reserve Index (ORI) Monitoring?
NCT07050719
Comparison of Oxygen Reserve Index and Spirometry in Predicting Respiratory Complications After Coronary Artery Bypass Surgery
NCT07063277
Oxygen Reserve Index in One-Lung Ventilation During Elective Thoracic Operations
NCT05050552
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
30 patients will bi included in our study; and they will be divided into two groups: In one group oxygenation management will be performed by conventional method, such as blood gas analysis. In other group ORI values will be used to manage oxygenation. Lung ultrasound will be performed in both groups to see if there will be any sign for atelectasis, preoperatively and postoperatively.
Kidney and liver functions will also be investigated before and after surgery. For cognitive disfunction evaluation; CAM-ICU scores will be recorded in both groups at 24 hours after the operation.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
DEVICE_FEASIBILITY
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Conventional group
The patient group that whose oxygenation will be managed by blood gas analysis.
ORI group
The patient group whose oxygenation will be managed by ORI values. Hyperoxia or hypoxia will be prevented by using also blood gas analysis in critically ill patients.
Conventional group
In this patient group oxygenation will be managed as usual, using blood gas analysis.
ORI group
The patient group that whose oxygenation will be managed by ORI values
ORI group
The patient group whose oxygenation will be managed by ORI values. Hyperoxia or hypoxia will be prevented by using also blood gas analysis in critically ill patients.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
ORI group
The patient group whose oxygenation will be managed by ORI values. Hyperoxia or hypoxia will be prevented by using also blood gas analysis in critically ill patients.
Conventional group
In this patient group oxygenation will be managed as usual, using blood gas analysis.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patients undergoing on-pump cardiac surgery
Exclusion Criteria
* Patients with advanced COPD (FEV1 \<60%)
* Patients with a history of CVD
* Patients with advanced carotid lesions (\> 50-70% of stenosis)
* Patients with renal failure
* Patients with liver failure
* Patients with cardiac arrhythmia
18 Years
75 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Bakirkoy Dr. Sadi Konuk Research and Training Hospital
OTHER_GOV
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Ipek Bostancı
Specialist, MD
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Bakirkoy Dr. Sadi Konuk Research and Training Hospital
Istanbul, Bakirkoy / Istanbul, Turkey (Türkiye)
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2020-281
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.